GlassScriptPhysician profile
Shwetha Shrivatsa
NPI 1699000158
$780.21
in general payments reported to CMS, 2019-2025
14 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.34 · 2020: $14.70 · 2021: $29.46 · 2022: $244 · 2023: $93.74 · 2024: $270 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $196.80 | 2021-2024 | Truclear |
| Astellas Pharma US INC | $142.12 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $76.06 | 2024-2025 | Aptima, Affirm Prone Biopsy System |
| Applied Medical Resources Corporation | $64.13 | 2022 | |
| Abbvie INC. | $63.99 | 2022-2023 | Liletta |
| Daiichi Sankyo INC. | $55.40 | 2021-2023 | Injectafer |
| Myovant Sciences INC. | $31.67 | 2022 | |
| Pfizer INC. | $30.85 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $29.04 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.79 | 2023 | |
| Organon LLC | $22.12 | 2024 | |
| Meditrina | $16.40 | 2025 | |
| Mylan Pharmaceuticals INC. | $15.00 | 2022 | |
| Scynexis, INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shwetha Shrivatsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.